Crimean Congo hemorrhagic fever: Is ribavirin an effective treatment? Researchers say they don’t know

In a viral haemorrhagic disease where up to 40% of people developing it die, it is remarkable that doctors still do not agree whether the only recognized treatment, an antiviral drug called ribavirin, makes a difference. In a new Cochrane Review a team of authors at LSTM, along with colleagues in London, The Philippines and ["]

The post Crimean Congo hemorrhagic fever: Is ribavirin an effective treatment? Researchers say they don't know appeared first on Outbreak News Today.